Skip to main content
. 2017 Feb;63(2):137–145.

Figure 1.

Figure 1.

Distribution of participants over time and at each 6-month retention evaluation point

DO—dropped out, NR—not yet reached 6-mo evaluation point.

*Because participants entered the program at different times, they reached the 6-mo follow-up intervals at different times. A total of 474 participants had been started on buprenorphine-naloxone at least 6 mo before the end of the data collection period.